| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/31/2011 | EP2361253A1 Compounds |
| 08/31/2011 | EP2361252A1 3h-imidazo [4, 5-c]pyridine-6-carboxamides as anti -inflammatory agents |
| 08/31/2011 | EP2361251A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/31/2011 | EP2361248A1 Heteroaryl compounds and uses thereof |
| 08/31/2011 | EP2361009A2 Electronic device including phenanthroline derivative |
| 08/31/2011 | EP2257545B1 Pyrrolidinyl derivatives and uses thereof |
| 08/31/2011 | EP2215054B1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/31/2011 | EP2173748B1 Indolyl pyrrolidines for the treatment of cancer |
| 08/31/2011 | EP2121683B1 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 08/31/2011 | EP2066667B1 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine |
| 08/31/2011 | EP1521754B1 Viral inhibitors |
| 08/31/2011 | CN102171211A Piperidine derivatives as JAK3 inhibitors |
| 08/31/2011 | CN102171210A Imidazopyridin-2-on derivative |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171202A Pyridine and pyrimidine based compounds as WNT signaling pathway inhibitors for the treatment of cancer |
| 08/31/2011 | CN102167699A Method for preparing nevirapine |
| 08/31/2011 | CN101370807B Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via GABA receptors |
| 08/31/2011 | CN101316818B 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/31/2011 | CN101268051B Isotopically substituted proton pump inhibitors |
| 08/31/2011 | CN101223167B Novel heteroaryl fused cyclic amines |
| 08/31/2011 | CN101155808B Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 08/31/2011 | CN101119968B Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/30/2011 | US8008491 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders |
| 08/30/2011 | US8008332 Substituted indazoles as glucokinase activators |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008320 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/30/2011 | US8008317 Inhibitors of akt activtiy |
| 08/30/2011 | US8008310 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 08/30/2011 | US8008287 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one |
| 08/30/2011 | US8008279 Compound—827 |
| 08/30/2011 | CA2672373C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/30/2011 | CA2531165C A method for the preparation of enantiomerically pure mirtazapine |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2438717C 6-phenylbenzonaphthyridines |
| 08/25/2011 | WO2011103509A1 Heterocyclic compounds and uses as anticancer agents |
| 08/25/2011 | WO2011103196A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain |
| 08/25/2011 | WO2011103007A2 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells |
| 08/25/2011 | WO2011102964A1 Heterocycles as potassium channel modulators |
| 08/25/2011 | WO2011102387A1 Method for producing reduced pyrroloquinoline quinone |
| 08/25/2011 | WO2011102348A1 Hydrazide chelate complex compound and optical recording medium using same |
| 08/25/2011 | WO2011101806A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 08/25/2011 | WO2011101805A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
| 08/25/2011 | WO2011101804A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
| 08/25/2011 | WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives |
| 08/25/2011 | WO2011101640A1 Fused heterocyclic compounds for use in the treatment of malaria |
| 08/25/2011 | WO2011101429A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use |
| 08/25/2011 | WO2011101304A2 Piperidine derivatives |
| 08/25/2011 | WO2011057706A3 Materials for electronic devices |
| 08/25/2011 | WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 08/25/2011 | US20110207767 Novel cc-1065 Analogs and Their Conjugates |
| 08/25/2011 | US20110207750 Benzimidazole and aza-benzimidazole carboxamides |
| 08/25/2011 | US20110207746 New compounds i |
| 08/25/2011 | US20110207738 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 08/25/2011 | US20110207732 Azaindole derivatives |
| 08/25/2011 | US20110207728 Compounds for treating respiratory syncytial virus infections |
| 08/25/2011 | US20110207721 Purine derivatives as kinase inhibitors |
| 08/25/2011 | US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators |
| 08/25/2011 | US20110207714 Serotonin receptor modulators |
| 08/25/2011 | US20110207711 Therapeutic Compounds |
| 08/25/2011 | US20110207700 Tricyclic compound and use thereof |
| 08/25/2011 | US20110206783 P2x3, receptor antagonists for treatment of pain |
| 08/25/2011 | US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors |
| 08/25/2011 | US20110204354 Indenopyrene compound and organic light-emitting device using the compound |
| 08/25/2011 | DE102010008613A1 New substituted perylene compounds, useful e.g. as pigments and colorants for dyeing purposes and for decorative purposes, as watercolor paints, water colors and inks for inkjet printers, and as material for leak testing of closed systems |
| 08/25/2011 | CA2790602A1 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells |
| 08/25/2011 | CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives |
| 08/25/2011 | CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain |
| 08/25/2011 | CA2789655A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 08/25/2011 | CA2789408A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
| 08/25/2011 | CA2789406A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
| 08/25/2011 | CA2789249A1 Heterocyclic compounds and uses as anticancer agents |
| 08/25/2011 | CA2789058A1 Piperidine derivatives |
| 08/25/2011 | CA2788783A1 Heterocycles as potassium channel modulators |
| 08/25/2011 | CA2786294A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use |
| 08/24/2011 | EP2360752A1 Organic electroluminescent element |
| 08/24/2011 | EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
| 08/24/2011 | EP2358687A1 Thioamide compounds, method of making and method of using thereof |
| 08/24/2011 | EP2358686A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators |
| 08/24/2011 | EP2358679A2 Process for making (r) - 3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido [2,3-d] pyrimidine-4,7 (3h,8h)-dione and intermediates thereof |
| 08/24/2011 | EP2358202A1 Benzimidazole and aza-benzimidazole carboxamides |
| 08/24/2011 | EP2358200A1 Substituted bicyclic amines for the treatment of diabetes |
| 08/24/2011 | EP1910366B1 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 08/24/2011 | EP1786815B1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | CN102164925A Tricyclic oxazolidinone antibiotic compounds |
| 08/24/2011 | CN102164924A 3H-imidaz0 [4, 5-B] pyridine- 6 -carboxamides as anti -inflammatory agents |
| 08/24/2011 | CN102164923A Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device |
| 08/24/2011 | CN102164922A 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti -inflammatory agents |
| 08/24/2011 | CN102164919A Oxazolidinyl antibiotics |
| 08/24/2011 | CN102161656A Caspase inhibitors and uses thereof |
| 08/24/2011 | CN101624393B Method for extracting cytosine and thermopsine from thermopsis lanceolata seeds |
| 08/24/2011 | CN101410385B Benzothiazoles having histamine H3 receptor activity |
| 08/23/2011 | US8003798 Respiratory system disorders |
| 08/23/2011 | US8003795 Compounds and compositions for reducing lipid levels |
| 08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
| 08/23/2011 | US8003663 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 08/23/2011 | US8003661 Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists |
| 08/23/2011 | US8003647 (Aza)indole derivative and use thereof for medical purposes |
| 08/23/2011 | US8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |